Literature DB >> 22739838

Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.

Cristiani F Bortolatto1, Cristiano R Jesse, Ethel A Wilhelm, Pietro M Chagas, Cristina W Nogueira.   

Abstract

This study was designed to evaluate the effects of bis selenide on Huntington disease (HD)-like signs induced by 3-nitropropionic acid (3-NP) in rats. To this aim, rats were treated for 4 days with bis selenide (5 or 20 mg/kg/day, per oral) 30 min before 3-NP (20 mg/kg/day, intraperitoneally). The body weight gain, locomotor activity, motor coordination, and biochemical parameters in striatal preparations were assessed 24 h after the last injection of 3-NP. The highest dose of bis selenide was effective in protecting against body weight loss and motor coordination deficit induced by 3-NP. The impairment of locomotor activity caused by 3-NP was abolished by bis selenide at both doses. Bis selenide (5 and 20 mg/kg) partially restored succinate dehydrogenase activity inhibited after 3-NP exposure. The dose of 20 mg/kg of bis selenide recovered partially δ-aminolevulinic acid dehydratase activity, and totally Na(+), K(+)-ATPase activity, two sulfhydryl enzymes sensitive to oxidizing agents, which had their activities inhibited by 3-NP. Also, 3-NP led to an increase in protein carbonyl levels and glutathione reductase activity and inhibited catalase activity-alterations that were reversed by bis selenide administration at both doses. The highest dose of bis selenide was effective against the increase of RS levels, the depletion of reduced glutathione content, and the inhibition of glutathione peroxidase activity induced by 3-NP. Bis selenide was not effective against inhibition of SOD activity caused by 3-NP. These findings demonstrate that bis selenide elicited protective effects against HD-like signs induced by 3-NP in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739838     DOI: 10.1007/s12640-012-9336-5

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  43 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

2.  Endogenous sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: neural regulation of genomic function.

Authors:  A Ravi Kumar; P A Kurup
Journal:  Neurol India       Date:  2002-06       Impact factor: 2.117

Review 3.  Development of biomarkers for Huntington's disease.

Authors:  David W Weir; Aaron Sturrock; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

Review 4.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

Authors:  E Mariani; M C Polidori; A Cherubini; P Mecocci
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-23       Impact factor: 3.205

5.  The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid.

Authors:  D Becker; D Viljoen; S Kramer
Journal:  Biochim Biophys Acta       Date:  1971-01-05

6.  Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease.

Authors:  M A Fontaine; J W Geddes; A Banks; D A Butterfield
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

7.  Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.

Authors:  Puneet Kumar; Anil Kumar
Journal:  J Med Food       Date:  2009-06       Impact factor: 2.786

8.  Mechanisms involved in the antinociceptive and anti-inflammatory effects of bis selenide in mice.

Authors:  Cristiano R Jesse; Lucielli Savegnago; Cristina W Nogueira
Journal:  J Pharm Pharmacol       Date:  2009-05       Impact factor: 3.765

9.  Spinal mechanisms of antinociceptive effect caused by oral administration of bis-selenide in mice.

Authors:  Cristiano R Jesse; Lucielli Savegnago; Cristina W Nogueira
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

10.  Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.

Authors:  C Verny; P Allain; A Prudean; M-C Malinge; B Gohier; C Scherer; D Bonneau; F Dubas; D Le Gall
Journal:  Eur J Neurol       Date:  2007-10-17       Impact factor: 6.089

View more
  2 in total

1.  Sodium selenite protects from 3-nitropropionic acid-induced oxidative stress in cultured primary cortical neurons.

Authors:  Dirleise Colle; Danúbia Bonfanti Santos; Viviane de Souza; Mark William Lopes; Rodrigo Bainy Leal; Patricia de Souza Brocardo; Marcelo Farina
Journal:  Mol Biol Rep       Date:  2018-12-03       Impact factor: 2.316

2.  Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.

Authors:  Mohamed S Abdelfattah; Sherif E A Badr; Sally A Lotfy; Gouda H Attia; Ahmed M Aref; Ahmed E Abdel Moneim; Rami B Kassab
Journal:  Neurotox Res       Date:  2019-07-22       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.